Major cancer research organizations are banding together to assess how cancer disparity research will move forward. In the first collaboration of its kind, the American Association for Cancer Research (AACR) announced Feb. 13 that the institute would be working with the American Cancer Society, the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI) to address concerns such as access to health care and factors related to variability of cancer outcomes.

Massachusetts Institute of Technology engineers have fashioned a smarter nanoparticle that runs RNA interference as a means of disease modification, the institute announced Feb. 10.

The use of an endothelialized microfluidic chip could be the key to understanding how nanoparticles in biomedicine behave in the presence of atherosclerosis, according to a study published online Jan. 6 in the Proceedings of the National Academy of Sciences.

Nanomedicine incorporates some of the most prized materials on earth in order to improve not only its biocompatibility and imaging potential, but its ability to sneak up on and change the way that cells function for the tiniest aspect of personalized medicine.

San Gabriel Valley Diagnostic Center (SGVDC) of West Covina, Calif., made its transition to digital imaging comparatively early, installing a PowerServer PACS from RamSoft in January of 2006.

Los Angeles-based ImaginAb is slated to collaborate with Duke-NUS Graduate School of Medicine and National Research Foundation Corp Lab on a $15 million imaging biomarker lab, ImaginAb announced Feb. 10.

A distribution contract has been struck between preclinical molecular imaging system manufacturer Sedecal headquartered in Spain and United Kingdom radiation oncology systems manufacturer Xstrahl Life Sciences, the company announced today.

An investigational immune-PET biomarker maps tumor vasculature while skipping healthy tissues, according to a study published Feb. 13 in the Journal of Nuclear Medicine.